Home » Topics » BioWorld Science

BioWorld Science
RSS

Ustekinumab biosimilar DMB-3115 begins phase I trial

Dec. 16, 2019

Funding supports Synedgen's optimization of therapies to restore GI integrity in IBD

Dec. 16, 2019

MHRA clears initiation of phase I trial of brilacidin delayed-release tablets

Dec. 16, 2019

LUSTER-1 and -2 results do not support further development of fevipiprant in asthma

Dec. 16, 2019

FDA approves Vascepa to reduce cardiovascular risk in adults with elevated triglyceride levels

Dec. 16, 2019

Chitotriosidase-1 levels rise prior to onset of ALS symptoms

Dec. 16, 2019

New PI3Kgamma/PI3Kdelta inhibitors synthesized at Incyte

Dec. 16, 2019

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent estrogen receptor antagonists

Dec. 16, 2019

New AXL/c-Met inhibitors disclosed by Shanghai Institute of Materia Medica

Dec. 16, 2019

Decoding EGFR's skin toxicity

Dec. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...